Literature DB >> 4304446

Markers of rubella virus strains in RK13 cell culture.

A Fogel, S A Plotkin.   

Abstract

When tested on RK(13) cell cultures, strains of rubella virus could be differentiated by their ability to form small or large plaques. Large plaques were produced by the HPV-77 and Cendehill strains, and also by a laboratory stock strain (West Point), after only 14 passages in RK(13) culture. Five wild-type rubella viruses, isolated and passaged only a few times in African green monkey kidney tissue culture, grew well in RK(13) cell culture, but they were sensitive to agar inhibitors and, therefore, formed small plaques. On the other hand, RA27/3, an attenuated strain grown in WI-38 human fibroblast cells, developed low titers in RK(13) cells and also produced small plaques. We concluded that the morphological differences between small-plaque and large-plaque viruses depended on their sensitivity to agar inhibitors and on the pH of the medium during plaque formation.

Entities:  

Mesh:

Substances:

Year:  1969        PMID: 4304446      PMCID: PMC375746     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  15 in total

1.  VIRULENCE AND INTERFERON PRODUCTION OF STRAINS OF FOOT-AND MOUTH DISEASE VIRUS.

Authors:  R F SELLERS
Journal:  J Immunol       Date:  1964-07       Impact factor: 5.422

2.  ISOLATION OF RUBELLA VIRUS FROM CASES IN BRITAIN.

Authors:  K MCCARTHY; C H TAYLOR-ROBINSON; S E PILLINGER
Journal:  Lancet       Date:  1963-09-21       Impact factor: 79.321

3.  PLAQUING OF RUBELLA VIRUS IN RK 13 CELLS.

Authors:  S A PLOTKIN
Journal:  Arch Gesamte Virusforsch       Date:  1965

4.  Heterogeneity of Coxsackie B4 virus: two kinds of particles which differ in antibody sensitivity, growth rate, and plaque size.

Authors:  P W CHOPPIN; H J EGGERS
Journal:  Virology       Date:  1962-11       Impact factor: 3.616

5.  Chemical mutagenesis of Newcastle disease virus.

Authors:  L THIRY
Journal:  Virology       Date:  1963-02       Impact factor: 3.616

6.  A simple method for concentration of live and formaldehyde-inactivated poliovirus.

Authors:  N GROSSOWICZ; A MERCADO; N GOLDBLUM
Journal:  Proc Soc Exp Biol Med       Date:  1960-04

7.  Phase variation in ECHO virus type 6.

Authors:  D T KARZON; B F POLLOCK; A L BARRON
Journal:  Virology       Date:  1959-12       Impact factor: 3.616

8.  Attenuation of rubella virus by serial passage in primary rabbit kidney cell cultures. II. Experiments in animals.

Authors:  C Huygelen; J Peetermans
Journal:  Arch Gesamte Virusforsch       Date:  1967

9.  An attenuated rubella virus strain adapted to primary rabbit kidney.

Authors:  S A Plotkin; J Farquhar; M Katz; A Prinzie; T H Ongalls
Journal:  Am J Epidemiol       Date:  1968-07       Impact factor: 4.897

10.  Studies of immunization with living rubella virus. Trials in children with a strain cultured from an aborted fetus.

Authors:  S A Plotkin; D Cornfeld; T H Ingalls
Journal:  Am J Dis Child       Date:  1965-10
View more
  8 in total

1.  A novel plaque method for attenuated rubella virus in Vero cell cultures. Brief report.

Authors:  H Sato; P Albrecht; F A Ennis
Journal:  Arch Virol       Date:  1979       Impact factor: 2.574

2.  Mapping of genetic determinants of rubella virus associated with growth in joint tissue.

Authors:  K D Lund; J K Chantler
Journal:  J Virol       Date:  2000-01       Impact factor: 5.103

3.  Inability of rubella virus interference to reverse the inhibition of cellular protein synthetis caused by poliovirus.

Authors:  R Thomssen; E Suhrkamp; S Bonk
Journal:  Arch Gesamte Virusforsch       Date:  1972

4.  Genetic stability in humans of the rabbit immunogenic marker of Cendehill rubella vaccine virus.

Authors:  S D Gill; J Furesz
Journal:  Arch Gesamte Virusforsch       Date:  1973

5.  An unusual plaque variant of rubella virus.

Authors:  J J Gould; G D Laurence; M Butler
Journal:  J Hyg (Lond)       Date:  1972-03

6.  Predominant inflammatory cytokine secretion pattern in response to two doses of live rubella vaccine in healthy vaccinees.

Authors:  Neelam Dhiman; Iana H Haralambieva; Robert A Vierkant; V Shane Pankratz; Jenna E Ryan; Robert M Jacobson; Inna G Ovsyannikova; Gregory A Poland
Journal:  Cytokine       Date:  2010-02-01       Impact factor: 3.861

7.  The effect of diethylaminoethyl dextran and agar overlay pH on plaque formation by two plaque-size variants of foot-and-mouth disease virus.

Authors:  J S Martinsen
Journal:  Can J Comp Med       Date:  1970-01

8.  Analysis of VSV pseudotype virus infection mediated by rubella virus envelope proteins.

Authors:  Masafumi Sakata; Hideki Tani; Masaki Anraku; Michiyo Kataoka; Noriyo Nagata; Fumio Seki; Maino Tahara; Noriyuki Otsuki; Kiyoko Okamoto; Makoto Takeda; Yoshio Mori
Journal:  Sci Rep       Date:  2017-09-14       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.